Showing items 1 - 20 of 117

Your selections:

The emerging role of artificial intelligence in multiple sclerosis imaging

Automatic prediction of the conversion of clinically isolated syndrome to multiple sclerosis using deep learning

Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis

Fast magnetic resonance spectroscopic imaging techniques in human brain-applications in multiple sclerosis

Diurnal stability and long-term repeatability of neurometabolites using single voxel 1H magnetic resonance spectroscopy

Neural diffusion tensor imaging metrics correlate with clinical measures in people with relapsing-remitting MS

Altered in vivo brain GABA and glutamate levels are associated with multiple sclerosis central fatigue

Evaluation of MS related central fatigue using MR neuroimaging methods: scoping review

Diurnal variability of cerebral metabolites in healthy human brain with two-dimensional localised correlation spectroscopy (2D L-COSY)

CD4+ T-cell DNA methylation changes during pregnancy significantly correlate with disease-associated methylation changes in autoimmune diseases

Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20

Comparison of the sagittal sinus cross-sectional area between patients with multiple sclerosis, hydrocephalus, intracranial hypertension and spontaneous intracranial hypotension: a surrogate marker of venous transmural pressure?

A comparison between the pathophysiology of multiple sclerosis and normal pressure hydrocephalus: is pulse wave encephalopathy a component of MS?

The incidence of transverse sinus stenosis in multiple sclerosis: further evidence of pulse wave encephalopathy

Possible Markers of Venous Sinus Pressure Elevation in Multiple Sclerosis: Correlations with Gender and Disease Progression

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

Common and low frequency variants in MERTK are independently associated with multiple sclerosis susceptibility with discordant association dependent upon HLA-DRB1*15:01 status

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies

  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit